ArticleAlimentary pharmacology & therapeutics2015
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases.
A N Ananthakrishnan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled ittrialcites it